ghk-cu clinical trials safety efficacy Peptide Injection: Considerations – PlexusDx GHK-Cu Peptides: Unlocking the Copper

Zinc is most commonly included as part of an immunity-focused formulation but may be added to other infusions when clinically appropriate and assessed on an individual basis

Grange C, et al

Standard AOD-9604 Dosing Protocol Typical Dosing Range: Standard Dose: 250-500 mcg per day Clinical Trial Dose: 1 mg (1,000 mcg) per day (most effective in studies) Conservative Start: 250 mcg per day for first week Maintenance Range: 500 mcg per day for sustained protocols Frequency: Once daily, typically before breakfast Timing Rationale: Morning fasted state maximizes fat oxidation potential Cycle Length: 12-24 weeks for body composition protocols Administration Route: Subcutaneous injection (abdomen, thigh, or upper arm) Reconstitution: Bacteriostatic water, standard peptide protocols Note: Clinical trials used oral formulations, but subcutaneous administration is more common in current use due to improved bioavailability

Diabetes mellitus was defined as fasting plasma glucose concentration 126 mg/dL, or random/casual plasma glucose concentration 200 mg/dL, or Oral Glucose Tolerance Test 200 mg/dL, or HbA1c 6.5%, or taking antidiabetic medication, or ever been informed of a diagnosis of diabetes by a physician